Nanocarriers: a tool to overcome biological barriers in siRNA delivery

被引:11
|
作者
Kumari, Avnesh [1 ]
Kumar, Vineet [1 ]
Yadav, Sudesh Kumar [1 ]
机构
[1] CSIR, Inst Himalayan Bioresource Technol, Div Biotechnol, Nanobiol Lab, Palampur 176061, Himachal Prades, India
关键词
conjugation; encapsulation; nanocarriers; siRNA; SMALL INTERFERING RNA; POLYELECTROLYTE COMPLEX MICELLES; IN-VIVO; GOLD NANOPARTICLES; INTRACELLULAR DELIVERY; TARGETED DELIVERY; SYSTEMIC DELIVERY; CARBON NANOTUBES; QUANTUM DOTS; CANCER-CELLS;
D O I
10.1517/14712598.2011.587801
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Introduction: siRNA has poor in vivo stability and has a plasma half life of only a few minutes after intravenous administration. These problems can be overcome by conjugating/encapsulating siRNA with various nanosystems. Surface modifications of such nanosystems can further improve the cellular uptake of siRNA-nanosystems. In this review, the authors have highlighted the problems encountered in siRNA delivery, conjugation strategies and nanosystems for siRNA delivery and for improving their in vivo delivery performance. Areas covered: The authors briefly cover various problems encountered in siRNA delivery and discuss nanocarriers for overcoming these biological barriers. Expert opinion: siRNA binding and unpacking are important factors for optimizing the interactions between siRNA and nanosystems. Several crucial conjugation parameters, such as the conjugation site of siRNA, and the nature of molecules to be conjugated (charge, molecular weight and hydrophobicity), should be carefully considered for maximising delivery efficiency of siRNA conjugated nanosystems.
引用
收藏
页码:1327 / 1339
页数:13
相关论文
共 50 条
  • [41] Engineering nano-drug biointerface to overcome biological barriers toward precision drug delivery
    Waheed, Saquib
    Li, Zhibin
    Zhang, Fangyingnan
    Chiarini, Anna
    Armato, Ubaldo
    Wu, Jun
    JOURNAL OF NANOBIOTECHNOLOGY, 2022, 20 (01)
  • [42] Engineering nano-drug biointerface to overcome biological barriers toward precision drug delivery
    Saquib Waheed
    Zhibin Li
    Fangyingnan Zhang
    Anna Chiarini
    Ubaldo Armato
    Jun Wu
    Journal of Nanobiotechnology, 20
  • [43] Knocking down barriers: advances in siRNA delivery
    Kathryn A. Whitehead
    Robert Langer
    Daniel G. Anderson
    Nature Reviews Drug Discovery, 2009, 8 : 129 - 138
  • [44] Knocking down barriers: advances in siRNA delivery
    Whitehead, Kathryn A.
    Langer, Robert
    Anderson, Daniel G.
    NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (02) : 129 - 138
  • [45] Nanocarriers: A Reliable Tool for the Delivery of Anticancer Drugs
    Sabit, Hussein
    Abdel-Hakeem, Mohamed
    Shoala, Tahsin
    Abdel-Ghany, Shaimaa
    Abdel-Latif, Mokhtar Mamdouh
    Almulhim, Jawaher
    Mansy, Mohamed
    PHARMACEUTICS, 2022, 14 (08)
  • [46] Transport barriers and strategies of antitumor nanocarriers delivery system
    Zhang, Lin
    Wang, Yazhou
    Cao, Yang
    Lou, Deshuai
    Wang, Bochu
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2013, 101 (12) : 3661 - 3669
  • [47] Biological Barriers to Therapy with Antisense and siRNA Oligonucleotides
    Juliano, R.
    Bauman, J.
    Kang, H.
    Ming, X.
    MOLECULAR PHARMACEUTICS, 2009, 6 (03) : 686 - 695
  • [48] Lysosomal escaped protein nanocarriers for nuclear-targeted siRNA delivery
    Cao, Xiuping
    Shang, Xinxin
    Guo, Yingshu
    Zheng, Xiaofei
    Li, Wenxin
    Wu, Di
    Sun, Li
    Mu, Shanliang
    Guo, Chuanen
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2021, 413 (13) : 3493 - 3499
  • [49] Lysosomal escaped protein nanocarriers for nuclear-targeted siRNA delivery
    Xiuping Cao
    Xinxin Shang
    Yingshu Guo
    Xiaofei Zheng
    Wenxin Li
    Di Wu
    Li Sun
    Shanliang Mu
    Chuanen Guo
    Analytical and Bioanalytical Chemistry, 2021, 413 : 3493 - 3499
  • [50] Polymer nanocarriers for the delivery of small fragments of nucleic acids: Oligonucleotides and siRNA
    de Martimprey, H.
    Vauthier, C.
    Malvy, C.
    Couvreur, P.
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2009, 71 (03) : 490 - 504